Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...
A surprising new study suggests that COVID-19 may not have originated from bats or pangolins, but rather from a rare fusion ...
The Biomarkers Market is expected to grow from USD 79.3 billion in 2023-e to USD 187.4 billion by 2030, at a CAGR of 14.7% ...
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...
According to Future Market Insights’ updated report, the renal biomarker market is projected to experience steady growth over ...
Lunit offers free AI biomarker services to SITC researchers for immuno-oncology studies Global researchers gain access to ...
Lunit and SITC collaborate to offer SITC members exclusive access to Lunit SCOPE IO for AI-driven tumor microenvironment analysis. SITC is the world's leading member-driven organization specifically ...
4 天
News Medical on MSNAI approach reveals possible fusion of rare diseases in COVID-19 origins In A Landmark Dis...Despite extensive research, the origins of COVID-19 remain elusive. In a new study published in the KeAi journal Advances in Biomarker Sciences and Technology (ABST), an AI-driven approach was adopted ...
Additionally, liquid biopsy technology has made biomarker testing more accessible and non-invasive, allowing for early diagnosis and continuous monitoring. Advances in next-generation sequencing ...
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果